Skip to Main content Skip to Navigation
New interface
Journal articles

Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review

Abstract : Introduction: Cocaine use disorder is a chronic disease with severe consequences and a high relapse rate. There is a critical need to explore the factors influencing relapse in order to achieve more efficient treatment outcomes. Furthermore, there is a great need for easy-to-measure, repeatable, and valid biomarkers that can predict treatment response or relapse. Methods: We reviewed the available literature on the Pubmed database concerning the biomarkers associated with relapse in CUD, including central nervous system-derived, genetic, immune, oxidative stress, and “other” biomarkers. Results: Fifty-one articles were included in our analysis. Twenty-five imaging brain anatomic and function assessment studies, mostly using fMRI, examined the role of several structures such as the striatum activity in abstinence prediction. There were fewer studies assessing the use of neuropsychological factors, neurotrophins, or genetic/genomic factors, immune system, or oxidative stress measures to predict abstinence. Conclusion: Several biomarkers have been shown to have predictive value. Prospective studies using combined multimodal assessments are now warranted.
Complete list of metadata
Contributor : Cynthia Marie-Claire Connect in order to contact the contributor
Submitted on : Friday, October 7, 2022 - 4:52:34 PM
Last modification on : Tuesday, October 18, 2022 - 4:31:32 AM


Poireau et al 2022 Brain Scien...
Publication funded by an institution



Margaux Poireau, Thomas Milpied, Angéline Maillard, Christine Delmaire, Emmanuelle Volle, et al.. Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review. Brain Sciences, 2022, 12 (8), pp.1013. ⟨10.3390/brainsci12081013⟩. ⟨hal-03784434⟩



Record views


Files downloads